OD JETRE DO ZGLOBOVA : GDJE HEPAOTOLOGIJA SUSREĆE REUMATOLOGIJU

Authors:

Sandra Milić

Summary

Liver diseases represent an important, but often under-recognized comorbidity in patients with systemic rheumatic diseases. The connection between rheumatology and hepatology is multifaceted and includes shared immunopathogenetic mechanisms, a higher incidence of autoimmune liver diseases in certain rheumatic diseases, liver involvement in systemic autoimmune diseases, viral hepatitis with rheumatological manifestations, and hepatotoxicity of antirheumatic and immunosuppressive drugs. A special clinical problem is the patient with elevated liver findings during immunosuppressive treatment, in which the activity of the underlying disease, autoimmune liver disease, viral hepatitis, metabolically related steatotic liver disease, and drug-induced liver damage should be distinguished. In patients starting biological or targeted synthetic therapy, it is necessary to timely recognize chronic or previously recovered hepatitis B virus infection due to the possibility of reactivation, while hepatitis C may be associated with arthritis, sicca symptoms, and cryoglobulinemic vasculitis. A modern approach requires individualized risk assessment and close collaboration between rheumatologists and hepatologists. The aim of this review is to present the most important clinical links between rheumatology and hepatology and to offer a practical approach to the diagnosis and treatment of patients with overlapping rheumatic and liver diseases.

Sažetak
Bolesti jetre predstavljaju važnu, ali često nedovoljno prepoznat komorbiditet u bolesnika sa sistemskim reumatskim bolestima. Povezanost reumatologije i hepatologije višestruka je i obuhvaća zajedničke imunopatogenetske mehanizme, učestaliju pojavnost autoimunih bolesti jetre u pojedinim reumatskim bolestima, jetrenu zahvaćenost u sklopu sistemskih autoimunih bolesti, virusne hepatitise s reumatološkim manifestacijama te hepatotoksičnost antireumatskih i imunosupresivnih lijekova. Poseban klinički problem predstavlja bolesnik s povišenim jetrenim nalazima tijekom imunosupresivnog liječenja, pri čemu treba razlikovati aktivnost osnovne bolesti, autoimunu bolest jetre, virusni hepatitis, metabolički povezanu steatotičnu bolest jetre i lijekovima uzrokovano oštećenje jetre. U bolesnika koji započinju biološku ili ciljanu sintetsku terapiju nužno je pravodobno prepoznati kroničnu ili prethodno preboljelu infekciju virusom hepatitisa B zbog mogućnosti reaktivacije, dok hepatitis C može biti povezan s artritisom, sicca simptomima i krioglobulinemijskim vaskulitisom. Suvremeni pristup zahtijeva individualiziranu procjenu rizika i blisku suradnju reumatologa i hepatologa. Cilj ovog preglednog rada jest prikazati najvažnije kliničke poveznice između reumatologije i hepatologije te ponuditi praktičan pristup dijagnostici i liječenju bolesnika u kojem se preklapaju reumatska i jetrena bolest.

Vol.: Reumatizam 2026;73(Supl 1/Suppl 1):1–6